Global overview of injecting drug use and HIV infection among injecting drug users
Dados Bibliográficos
| ID | 23326757 |
|---|---|
| Autores | Carmen Aceijas (United Nations, autor correspondente), Gerry V Stimson (0000-0001-9559-0207, United Nations), Matthew Hickman (0000-0001-9864-459X, United Nations), Tammy Rhodes (0000-0003-2400-9838, United Nations), Tim Rhodes |
| Ano | 2004 |
| Volume | 18 |
| Fascículo | 17 |
| Páginas | 2295-2303 |
| Data de publicação | 2004-11-01 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | AIDS (JOURNAL) |
| Identificadores do periódico | ISSN: 0269-9370 • E-ISSN: 1473-5571 |
| Editora | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00002030-200411190-00010 |
| PMID | 15577542 |
| OpenAlex | W1975806001 |
| Idioma | EN |
| Citações recebidas | 68 |
| Referências citadas | 5 |
OBJECTIVE: To provide global estimates of the prevalence of injecting drug use (IDU) and HIV prevalence among IDU, in particular to provide estimates for developing and transitional countries. METHODS: Collation and review of existing estimates of IDU prevalence and HIV prevalence from published and unpublished documents for the period 1998-2003. The strength of evidence for the information was assessed based on the source and type of study. RESULTS: Estimates of IDU prevalence were available for 130 countries. The number of IDU worldwide was estimated as approximately 13.2 million. Over ten million (78%) live in developing and transitional countries (Eastern Europe and Central Asia, 3.1 million; South and South-east Asia, 3.3 million; East-Asia and Pacific, 2.3 million). Estimates of HIV prevalence were available for 78 countries. HIV prevalence among IDU of over 20% was reported for at least one site in 25 countries and territories: Belarus, Estonia, Kazakhstan, Russia, Ukraine, Italy, Netherlands, Portugal, Serbia and Montenegro, Spain, Libya, India, Indonesia, Malaysia, Myanmar, Nepal, Thailand, Viet Nam, China, Argentina, Brazil, Uruguay, Puerto Rico, USA and Canada. CONCLUSIONS: These findings update previous assessments of the number of countries with IDU and HIV-infected IDU, and the previous quantitative global estimates of the prevalence of IDU. However, gaps remain in the information and the strength of the evidence often was weak.
China · Developing country · Economic growth · Environmental health · Geography · Human immunodeficiency virus (HIV) · Montenegro · Socioeconomics · Census and Population Estimation · Demography · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Virology
Effectiveness of community-based outreach in preventing HIV/Aids among injecting drug users
Overlap between harm reduction and HIV service utilisation among PWID in India
Factors associated with injury and blood-borne infection risk when providing assisted injection among people who inject drugs
Tracking coverage on the silk road
Disorders of Impulse Control
Correlates of injection drug use among female sex workers in two Mexico–U.S. border cities
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Global epidemiology of injecting drug use and HIV among people who inject drugs
Substance Abuse and Psychiatric Disorders in HIV-Positive Patients
Resilience, Distress, and Dependence Influence Injection Related Risk among People Who Inject Drugs
The intersection between sex and drugs
Using standardized methods for research on HIV and injecting drug use in developing/transitional countries
Let It “B”? The Role of Hepatitis B Universal Vaccination among Italian Problematic Drug Users
HIV prevalence and factors associated with HIV infection among male injection drug users under 30
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
‘Sometimes I feel like the other life on heroin was better’
HIV/Aids, Religion, and Human Rights
HIV transmission as a result of drug market violence
Vietnam moves forward with harm reduction
HIV prevention for injection drug users in China and Vietnam
Estimating injection drug use prevalence using state wide administrative data sources
Illegal drug markets in transitional economies
Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014
Dangerous Subtlety
A Surveillance Report of HIV Status and High Risk Behaviors Among Rapid Testing Participants in Tallinn, Estonia
Illicit Drug Users in the Tanzanian Hinterland
Hazardous Drinking and HIV Sexual Risk Behaviors Among Injection Drug Users in Developing and Transitional Countries
HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi
HIV Prevalence and Risk Behaviors Among People Who Inject drugs in Two Serial Cross-Sectional Respondent-Driven Sampling Surveys, Zanzibar 2007 and 2012
Estimating the Number of People Who Inject Drugs, Female Sex Workers, and Men Who Have Sex with Men, Unguja Island, Zanzibar
HIV Seroprevalence among High-Risk Groups in Kohgiloyeh and Boyerahmad Province, Southwest of Iran, a Behavioral Surveillance Survey
Addressing Health Disparities Among Men
Experience of hepatitis C testing among injecting drug users in Sydney, Australia
Risky behaviors for HIV infection among male incarcerated injection drug users in Taiwan
HIV Prevention for Injecting Drug Users
The Prevalence of HIV, HBV, HCV, and HIV-Related Risk-Taking Behaviors among Palestinian Injecting Drug Users in the East Jerusalem Governorate
Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan
Re-examining blood donor deferral criteria relating to injecting drug use
Malaysia and harm reduction
The Global Fund's leadership on harm reduction
Implementation of harm reduction in Central and Eastern Europe and Central Asia
Integration and co-location of HIV/Aids, tuberculosis and drug treatment services
HIV risk and the overlap of injecting drug use and high-risk sexual behaviours among men who have sex with men in Zanzibar (Unguja), Tanzania
Case study
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
Hepatitis B vaccination and injecting drug use
Evidence for Action
Route transition interventions
Peer-to-peer injection
Assisted injection provider practices and motivations in Los Angeles and San Francisco California 2016–18
Advocacy for harm reduction in China
Antiretroviral HIV treatment and care for injecting drug users
Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs)
Managing information
A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia
Global estimates of prevalence of HCV infection among injecting drug users
HIV, Aids and conflict in Africa
Modeling the impact of supra-structural network nodes
Utilization of HIV/Aids treatment services
The contribution of two Brazilian multi-center studies to the assessment of HIV and HCV infection and prevention strategies among injecting drug users
Reconstructing the Aids epidemic among injection drug users in Brazil
Access to highly active antiretroviral therapy for injection drug users
Examining attribution model of self-stigma on social support and psychological well-being among people with HIV+/Aids
Sex, drugs, and HIV
Injection Drug Users' Access to a Supervised Injection Facility in Vancouver, Canada
The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA
More free syringes, fewer drug injectors in the case of Spain
Human rights and universal access for men who have sex with men and people who inject drugs
| Obras citantes distintas | 68 |
|---|---|
| Citações por ano | 3,24 |
| Intervalo de citações | 2005 - 2021 (17) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 64 |